This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liau, S.-S. Articles by Whang, E. E. Search for Related Content PubMed PubMed Citation Articles by Liau, S.-S. Articles by Whang, E. E.

HMGA1 Is a Determinant of Cellular Invasiveness and In vivo Metastatic Potential in Pancreatic Adenocarcinoma

Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

Requests for reprints: Edward E. Whang, Department of Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115. Phone: 617-732-8669; Fax: 617-739-1728; E-mail: ewhang1{at}partners.org.

HMGA1 proteins are architectural transcription factors that are overexpressed in a range of human malignancies, including pancreatic adenocarcinoma. We hypothesized that HMGA1 expression is a determinant of cellular invasiveness and metastasis in pancreatic cancer. Stable silencing of HMGA1 in MiaPaCa2 and PANC1 pancreatic adenocarcinoma cells was achieved by transfection of short hairpin RNA–generating vectors. Additionally, stable overexpression of HMGA1 in MiaPaCa2 cells (characterized by low levels of inherent HMGA1 expression) was achieved. HMGA1 silencing resulted in significant reductions in cellular invasiveness through Matrigel; in cellular matrix metalloproteinase-9 (MMP-9) activity, mRNA levels, and gene promoter activity; and in Akt phosphorylation at Ser⁴⁷³. Conversely, forced HMGA1 overexpression resulted in significant increases in cellular invasiveness; in cellular MMP-9 activity, mRNA levels, and promoter activity; and in Akt phosphorylation at Ser⁴⁷³. HMGA1 overexpression–induced increases in invasiveness were MMP-9 dependent. The role of phosphatidylinositol-3 kinase (PI3K)/Akt in mediating HMGA1-dependent invasiveness was elucidated by a specific PI3K inhibitor (LY294002) and constitutively active and dominant-negative Akt adenoviral constructs. Akt-dependent modulation of MMP-9 activity contributed significantly to HMGA1 overexpression–induced increases in invasive capacity. Furthermore, HMGA1 silencing resulted in reductions in metastatic potential and tumor growth in vivo and in tumoral MMP-9 activity. Our findings suggest that HMGA1 may be a novel molecular determinant of invasiveness and metastasis, as well as a potential therapeutic target, in pancreatic adenocarcinoma. (Cancer Res 2006; 66(24): 11613-22)

This article has been cited by other articles:

				H. P. Gaide Chevronnay, C. Galant, P. Lemoine, P. J. Courtoy, E. Marbaix, and P. Henriet Spatiotemporal Coupling of Focal Extracellular Matrix Degradation and Reconstruction in the Menstrual Human Endometrium Endocrinology, November 1, 2009; 150(11): 5094 - 5105. [Abstract] [Full Text] [PDF]

				J. Hillion, L. J. Wood, M. Mukherjee, R. Bhattacharya, F. Di Cello, J. Kowalski, O. Elbahloul, J. Segal, J. Poirier, C. M. Rudin, et al. Upregulation of MMP-2 by HMGA1 Promotes Transformation in Undifferentiated, Large-Cell Lung Cancer Mol. Cancer Res., November 1, 2009; 7(11): 1803 - 1812. [Abstract] [Full Text] [PDF]

				S. Watanabe, Y. Ueda, S.-i. Akaboshi, Y. Hino, Y. Sekita, and M. Nakao HMGA2 Maintains Oncogenic RAS-Induced Epithelial-Mesenchymal Transition in Human Pancreatic Cancer Cells Am. J. Pathol., March 1, 2009; 174(3): 854 - 868. [Abstract] [Full Text] [PDF]

				J. P. Venables, R. Klinck, A. Bramard, L. Inkel, G. Dufresne-Martin, C. Koh, J. Gervais-Bird, E. Lapointe, U. Froehlich, M. Durand, et al. Identification of Alternative Splicing Markers for Breast Cancer Cancer Res., November 15, 2008; 68(22): 9525 - 9531. [Abstract] [Full Text] [PDF]

				S.-S. Liau and E. Whang HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma Clin. Cancer Res., March 1, 2008; 14(5): 1470 - 1477. [Abstract] [Full Text] [PDF]

				J. E. Adair, S. C. Maloney, G. A. Dement, K. J. Wertzler, M. J. Smerdon, and R. Reeves High-Mobility Group A1 Proteins Inhibit Expression of Nucleotide Excision Repair Factor Xeroderma Pigmentosum Group A Cancer Res., July 1, 2007; 67(13): 6044 - 6052. [Abstract] [Full Text] [PDF]